Physician profile
Ryan V Commiskey
NPI 1922510577
$17,611.00
in general payments reported to CMS, 2019-2025
71 companies · $4,596 in 2025
The $4,596 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,566 · 2022: $2,547 · 2023: $4,096 · 2024: $4,806 · 2025: $4,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $1,579 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,353.02 |
| Long Term Medical Supply Or Device Loan | $1,578.83 |
| Education | $566.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,823.58 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,409.45 | 2021-2025 | Enhertu, Imfinzi, Tagrisso |
| Janssen Biotech, INC. | $977.78 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Exelixis INC. | $826.02 | 2021-2025 | Cabometyx |
| Seagen INC. | $656.68 | 2021-2023 | Padcev, Adcetris, Tukysa |
| Celgene Corporation | $586.14 | 2022-2025 | Reblozyl, Opdualag, Breyanzi |
| Incyte Corporation | $584.77 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $551.08 | 2021-2025 | Keytruda, Welireg |
| Takeda Pharmaceuticals U.S.A., INC. | $546.98 | 2021-2025 | Alunbrig, Fruzaqla, Iclusig |
| E.R. Squibb & Sons, L.L.C. | $540.63 | 2021-2025 | Opdivo, Opdualag, Krazati |
| Daiichi Sankyo INC. | $506.21 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Genzyme Corporation | $453.72 | 2021-2025 | |
| Genentech USA, INC. | $423.96 | 2022-2025 | Alecensa, Phesgo, Gavreto |
| Eisai INC. | $423.67 | 2021-2025 | |
| Pfizer INC. | $385.48 | 2022-2025 |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $336.68 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $316.60 | 2021-2025 | |
| Karyopharm Therapeutics INC. | $313.50 | 2021-2025 | Xpovio |
| Sobi, INC | $312.51 | 2022-2025 | |
| Gilead Sciences, INC. | $295.76 | 2022-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $264.12 | 2021-2025 | |
| Lilly USA, LLC | $242.43 | 2022-2024 | Jaypirca, Retevmo, Verzenio |
| Regeneron Healthcare Solutions, INC. | $238.82 | 2022-2025 | Libtayo |
| Amgen INC. | $237.60 | 2021-2023 | Lumakras, Nplate, Xgeva |
| Stemline Therapeutics INC. | $210.10 | 2023-2025 | Orserdu |
| Puma Biotechnology, INC. | $198.02 | 2021-2023 | |
| Array Biopharma INC | $196.51 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Kite Pharma, INC. | $193.46 | 2022-2025 | Yescarta |
| Beigene USA, INC. | $174.52 | 2022-2025 | Brukinsa |
| Blueprint Medicines Corporation | $168.83 | 2021-2025 | Ayvakit |
| Emd Serono, INC. | $154.41 | 2023-2025 | Bavencio |
| Mirati Therapeutics, INC. | $149.61 | 2023-2024 | Krazati |
| Genmab U.S., INC. | $137.26 | 2023-2025 | Epkinly, Tivdak |
| Tersera Therapeutics LLC | $132.76 | 2023-2025 | Zoladex |
| Boston Scientific Corporation | $121.59 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Alexion Pharmaceuticals, INC. | $115.39 | 2022-2024 | Ultomiris |
| Glaxosmithkline, LLC. | $111.49 | 2024-2025 | Ojjaara, Jemperli, Zejula |
| Kyowa Kirin, INC. | $97.69 | 2021-2025 | Poteligeo |
| Taiho Oncology, INC. | $95.30 | 2021-2023 | |
| Pharmacyclics LLC, An Abbvie Company | $78.36 | 2022-2023 | Imbruvica |
| Pharmaessentia USA Corporation | $73.31 | 2024-2025 | Besremi |
| Apellis Pharmaceuticals, INC. | $64.09 | 2022-2025 | Empaveli |
| Ipsen Biopharmaceuticals, INC | $61.31 | 2022-2025 | Onivyde |
| Springworks Therapeutics, INC. | $54.48 | 2024-2025 | Ogsiveo |
| Beone Medicines USA, INC. | $52.58 | 2025 | Brukinsa, Tevimbra |
| Servier Pharmaceuticals LLC | $46.64 | 2024-2025 | |
| Geron Corporation | $45.03 | 2025 | Rytelo |
| Deciphera Pharmaceuticals INC. | $44.51 | 2024-2025 | Qinlock, Romvimza |
| Eusa Pharma (US) LLC | $43.57 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $42.80 | 2024 | |
| Rigel Pharmaceuticals, INC. | $42.34 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.82 | 2025 | |
| Astellas Pharma US INC | $35.66 | 2025 | Xtandi |
| Legend Biotech USA INC. | $32.82 | 2025 | Carvykti |
| G1 Therapeutics, INC. | $31.98 | 2022 | |
| Dendreon Pharmaceuticals LLC | $30.02 | 2024 | Provenge |
| Pharmacosmos Therapeutics INC. | $28.46 | 2023-2025 | Monoferric |
| Menarini Silicon Biosystems, INC. | $24.72 | 2025 | |
| Myovant Sciences INC. | $23.76 | 2022 | |
| Acrotech Biopharma INC. | $22.69 | 2024 | Beleodaq |
| Heron Therapeutics, INC. | $21.47 | 2023 | Cinvanti |
| Nuvation Bio INC. | $21.39 | 2025 | Ibtrozi |
| Progenics Pharmaceuticals, INC. | $20.60 | 2023 | Pylarify |
| Cti Biopharma Corp. | $19.17 | 2023 | Vonjo |
| Agios Pharmaceuticals, INC. | $17.01 | 2022 | |
| Coopersurgical, INC. | $16.62 | 2025 | Paragard T 380a |
| Adaptive Biotechnologies Corporation | $16.11 | 2025 | Clonoseq |
| Caris Mpi, INC. | $14.52 | 2025 | Mi Cancer Seek |
| Fresenius Kabi USA, LLC | $13.71 | 2024 | Stimufend |
| Mylan Institutional INC. | $12.99 | 2022 | |
| Sun Pharmaceutical Industries INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
Kisqali $1,968Enhertu $701Reblozyl $466Pluvicto $432Keytruda $429Cabometyx $414Lenvima $294Doptelet $285Venclexta $264Jakafi $237Sarclisa $231Xpovio $227Darzalex $217Orserdu $210Krazati $206Libtayo $206Opdualag $205Imfinzi $197Tukysa $193Xtandi $193Opdivo $189Lutathera $182Tagrisso $180Brukinsa $178Imbruvica $171Tecvayli $164Braftovi $163Talvey $162Ayvakit $156Rybrevant $154Zepzelca $139Nubeqa $135Mektovi $134Alunbrig $134Zoladex $133Welireg $128Erleada $127Epkinly $117Stivarga $115Vitrakvi $115Alecensa $114Jaypirca $114Fruzaqla $113Gavreto $112Adcetris $110Xofigo $104Talzenna $102Ibrance $102Retevmo $100Ultomiris $100Yescarta $98.81Phesgo $98.75Therasphere Y90 Glass Microspheres 10 Gbq $98.72Monjuvi $98.00Ojjaara $96.53Rozlytrek $92.96Padcev $85.81Scemblix $84.90Trodelvy $84.76Lunsumio $83.19Bavencio $80.67Polivy $78.60Carvykti $78.28Lorbrena $77.69Tecentriq $75.16Iclusig $74.03Besremi $73.31Verzenio $73.27Inlyta $72.64Lynparza $65.71Orgovyx $63.40Columvi $63.13Perjeta $59.34Xalkori $59.11Enjaymo $58.46Cablivi $58.46Fabhalta $57.92Ogsiveo $54.48Bosulif $46.20Onivyde $45.77Rytelo $45.03Qinlock $44.51Fotivda $42.80Rezlidhia $42.34Tavalisse $42.34Poteligeo $42.12Pemazyre $38.97Itovebi $38.41Vonjo $35.05Injectafer $34.82Elrexfio $34.72Paxlovid $33.77Evusheld $32.89Empaveli $32.79Provenge $30.02Calquence $29.66Akeega $28.54Balversa $28.54Monoferric $28.46Lumakras $28.20
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Commiskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.